Macroflux Corporation selects R&D Logic Software.
November 2006 — Macroflux Corporation, located in Mountain View, California, has opted to use the R&D Logic complete enterprise solution for planning and tracking, and time collection. Macroflux is a spin-out of ALZA Corporation (a subsidiary of Johnson & Johnson). The Macroflux system is based on a small patch and applicator that is intended to provide a needle-free solution for transdermal delivery of therapeutic proteins, peptides and vaccines. It is designed to combine painless and convenient drug administration with rapid delivery and high bioavailability.
SGX Pharmaceuticals selects R&D Logic Software for Planning and Tracking.
October 2006 — SGX Pharmaceuticals Inc., located in San Diego, California, has decided to use R&D Logic enterprise solution to support FP&A company-wide processes. SGX Pharmaceuticals is a biotechnology company focused on the discovery, development and commercialization of innovative cancer therapeutics.
Alnylam Pharmaceuticals selects R&D Logic Software.
September 2006 — Alnylam Pharmaceuticals Inc., located in Cambridge, Massachusetts, has selected R&D Manage, R&D Time and R&D P&L to support corporate strategic and financial planning as well as monthly tracking and analysis. Alnylam Pharmaceuticals, a leader in RNAi therapeutics, is a biopharmaceutical company developing novel therapeutics based on a breakthrough in biology known as RNA interference, or RNAi.
Momenta Pharmaceuticals selects R&D Logic Enterprise Solution.
August 2006 — Momenta Pharmaceuticals Inc., located in Cambridge, Massachusetts, has selected R&D Logic suite of software to support planning and tracking, time collection and corporate analysis and financial reporting. Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the detailed structural analysis and design of complex sugars (polysaccharides) for the development of improved versions of existing drugs, the development of novel drugs, and the discovery of new biological processes.
InterMune chooses R&D Resource software.
July 2006 — InterMune Inc., located in Brisbane, California, has opted to use R&D Logic software to support Project Time collection as well Time off collecting and tracking, our latest addition to the enterprise solution. In addition, InterMune will be using software capabilities to track and analyze resource utilization by project and program. InterMune is a publicly traded biotech company focused on developing and commercializing innovative therapies in hepatology and pulmonology.
Titan Pharmaceuticals chooses R&D Logic suite for Planning and Tracking.
June 2006 — Titan Pharmaceuticals Inc., located in South San Francisco, California, has selected the full R&D Logic suite of software to support corporate planning and tracking, time collection, and financial reporting. Titan is a biopharmaceutical company focused on the development and commercialization of novel treatments for central nervous system disorders, cardiovascular disease, bone disease and other disorders.
Valentis selects R&D Time solution for tracking actual project effort.
December 2005 — Valentis, Inc., located in Burlingame, California, has selected R&D Time to replace in-house time and attendance system and complete the R&D Logic enterprise suite that has been in used for the past four years. Valentis is a biotechnology company engaged in the development of innovative products for peripheral arterial disease (PAD), a large and unsatisfied market.
NeuroMolecular selects R&D Logic solution for corporate planning and tracking.
August 2005 — NeuroMolecular Pharmaceuticals, Inc., located in Emeryville, California has selected R&D Manage™ and P&L platform to support project portfolio and corporate planning and tracking business processes. NeuroMolecular Pharmaceuticals is developing and commercializing superior neuroprotective medicines for the treatment of central nervous system (CNS) disorders.
Avidia selects R&D Logic enterprise solution for planning and tracking.
August 2005 — Avidia, Inc. located in Mountain View, California, has selected R&D Manage, R&D Time and R&D P&L to support corporate strategic and operational planning as well as monthly collecting and tracking. Avidia is focused on developing a new class of therapeutic proteins for treatments in areas including autoimmunity, inflammation and oncology.
R&D Time 3.1.1 Release Launch.
April 2005 — R&D Logic announces new product features for its R&D Time Module setting a new standard in integrating planning and resource time tracking software offerings.
R&D P&L Commercial Launch.
December 2004 — R&D P&L complements R&D Manage and supports the calculation, formatting, viewing (including drill-down) and direct download to Excel of a Company's Profit & Loss Statement. The module also automates allocations (Facility, G&A, &D, Cost of Goods Sold, etc.) required to produce a complete P&L statement.
R&D Manage™ 3.1 Release Launch.
December 2004 — R&D Manage 3.1 release has been rolled out to all customer. This new release incorporates functions in project resources and financials tracking, as well as new reporting tools.
R&D P&L 2.0 Release Launch.
December 2004 — R&D P&L has been enhanced with additional flexibility for defining financial reporting criteria as well as new publishing features for easy distribution. There are currently seven different companies that have purchased this application and are successfully using it for producing and distributing monthly and pro-forma financials.
Avigen selects R&D Logic solution for planning and tracking corporate financials.
October 2004 — Avigen, Inc. located in Alameda, California has selected R&D Manage and R&D Time software to support corporate and project planning and tracking activities. Avigen (NASDAQ: AVGN) is a leader in the development of gene therapy products to treat serious, chronic diseases.
R&D Time 1.0.
February 2004 — R&D Time 1.0 release has been commercially launched to two sites. The response from customers has been overwhelmingly positive and enthusiastic.
EPIX Pharmaceuticals selects R&D Time™ as the new company time & attendance solution.
January 2004 — Epix, who currently uses R&D Manage for their corporate budgeting and tracking, has decided to expand their usage of R&D Logic products and include R&D Time, a software tool specifically developed to collect project efforts by employee. R&D Time will replace the current time collection system.
EPIX Medical selects R&D Manage™ solution for planning and tracking resources by project.
November 2003 — EPIX Medical, Inc. located in Cambridge, Massachusetts has selected R&D Logic software solution and services for managing their corporate and project financials. EPIX Medical (NASDAQ: EPIX)is a specialty pharmaceutical company and a worldwide leader in the discovery and development of targeted MRI contrast agents for the diagnosis and clinical management of disease.
R&D Time Beta Customers.
November 2003 — Cytokinetics and Novacea have signed up as beta customers of our latest product under development, R&D Time. This new product facilitates capturing the employees' monthly effort by project along with providing electronic approvals, alerts and graphical analysis of project resources utilization across the corporation.
R&D Manage 3.0.
September 2003 — The R&D Manage 3.0 release has been rolled out to all customers. This major release introduces an enhanced reporting mechanism, a complete rewrite of most standard reports along with a new technology to seamlessly download reports to Excel. Customer response has been extremely enthusiastic.
BioMedicines selects R&D Manage™ solution to budget, forecast and track their financials and project resources.
August 2003 — BioMedicines, Inc. located in Emeryville, California has selected R&D Logic software solution and services for managing their corporate and project financials. BioMedicines specializes in developing and systematically generating new uses for clinical-stag drugs purchased or licensed from major pharmaceutical companies.